Market Overview:
The global insulin pen and pump market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin pens and pumps, and rising awareness about diabetes management. Based on type, the global insulin pen and pump market is segmented into insulin pens and insulin pumps. Insulin pens are further sub-segmented into disposable pens and reusable pens. Insulin pumps are further sub-segmented into external pumps and implantable pumps. The disposable pen segment is expected to grow at a higher CAGR than the reusable pen segment during the forecast period from 2018 to 2030 owing to their low cost as compared with reusable pens, easy handling, no need for priming or cleaning before use, portability, less risk of infection transmission due to reuse etc.
Product Definition:
Insulin pens and pumps are devices that help people with diabetes to control their blood sugar levels. Insulin is a hormone that helps the body to use glucose, or sugar, for energy. People with diabetes have trouble controlling their blood sugar levels because they do not produce enough insulin or cannot use insulin properly. Insulin pens and pumps help by delivering a controlled amount of insulin directly into the bloodstream.
Insulin Pens:
Insulin pens are the new trend in diabetes management. Insulin pen and pumps have been evolving gradually with technological advancements. The introduction of smart insulin pens has made the usage of these devices easy and convenient for patients, thereby boosting market growth.
Insulin pens are portable devices that deliver rapid-acting insulin through injection sites other than self-administration using a manual or automatic pump device.
Insulin Pump:
Insulin pen and pump are devices used to deliver insulin through injection sites. Insulin pens are small sized portable devices that consist of a thin tube for delivering the insulin into the body. The device is powered by a battery which can last up to two weeks with regular use. On the other hand, pumps are larger in size and have attached tubing which delivers liquid medication directly into the patient’s blood stream through an infusion set or subcutaneous implant site.
Application Insights:
The hospital and clinic application segment accounted for the largest revenue share in 2017. This is attributed to growing awareness about the availability of insulin pumps that are suitable for institutional use, coupled with an increase in the number of hospitals and clinics that offer these devices to their patients. Furthermore, a rise in healthcare expenditure has led to an increase in investments by governments into building new hospitals or renovating old ones, which has subsequently resulted in increased demand for insulin pumps.
The retail pharmacy application segment is expected to witness significant growth over the forecast period owing to increasing adoption of these devices as they provide flexibility as well as convenience while purchasing drugs from pharmacies or drug stores. Moreover, manufacturers have launched innovative products such as mini-pumps that can be used while shopping at supermarkets or grocery stores along with mobile apps connecting users with diabetes care teams offering recommendations on daily medication routines and food options related to diabetes management.
Regional Analysis:
North America dominated the global insulin pen and pump market in 2017. This can be attributed to the presence of a large number of manufacturers, suppliers, and brands in this region. The U.S., which is one of the most developed countries with high healthcare expenditure levels per capita, has a well-established distribution network for pharmaceutical products enabling easy access to patients across the country as well as worldwide through internet and phone orders without any extra charges or fees associated with it.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing demand for advanced diabetes devices coupled with rising patient awareness levels regarding these products along with their availability at an economical price range resulting in an increased adoption rate among individuals suffering from diabetes type 2 & 3 disorders thereby boosting market growth over projected time frame. Moreover, growing penetration rates for online retail pharmacies such as Amazon India Pvt Ltd., BigBasket (India) Pvt Ltd., Grofers (India) Pvt Ltd.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for insulin pen and pump devices, which can help in better managing blood sugar levels in diabetic patients.
- Technological advancements: The insulin pen and pump market is witnessing rapid technological advancements, with manufacturers introducing new products that are more user-friendly and offer greater accuracy and convenience than traditional devices. This is helping to drive growth in the market.
- Rising awareness about diabetes management: There has been a significant increase in awareness about diabetes management among people across the world in recent years. This has led to an increase in demand for insulin pen and pump devices as they offer a more convenient way to manage blood sugar levels than other methods such as oral medications or injections using syringes or vials..
Scope Of The Report
Report Attributes
Report Details
Report Title
Insulin Pen and Pump Market Research Report
By Type
Insulin Pens, Insulin Pump
By Application
Hospital & Clinic, Retail Pharmacy, Online Sales
By Companies
Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Insulin Pen and Pump Market Report Segments:
The global Insulin Pen and Pump market is segmented on the basis of:
Types
Insulin Pens, Insulin Pump
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinic, Retail Pharmacy, Online Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Medtronic
- Roche
- Insulet Corp
- Tandem Diabetes care
- Valeritas
- SOOIL
- Microport
Highlights of The Insulin Pen and Pump Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin Pens
- Insulin Pump
- By Application:
- Hospital & Clinic
- Retail Pharmacy
- Online Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insulin Pen and Pump Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Insulin pens and pumps are medical devices that help people with diabetes manage their blood sugar levels. They work by injecting insulin into a person's bloodstream, which helps to control the amount of sugar in the blood. Insulin pens and pumps can be used with either human or animal insulin, and come in different sizes to fit different body types.
Some of the major companies in the insulin pen and pump market are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport.
The insulin pen and pump market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insulin Pen and Pump Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Insulin Pen and Pump Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Insulin Pen and Pump Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Insulin Pen and Pump Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Insulin Pen and Pump Market Size & Forecast, 2020-2028
4.5.1 Insulin Pen and Pump Market Size and Y-o-Y Growth
4.5.2 Insulin Pen and Pump Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Insulin Pens
5.2.2 Insulin Pump
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital & Clinic
6.2.2 Retail Pharmacy
6.2.3 Online Sales
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insulin Pen and Pump Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insulin Pen and Pump Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Insulin Pens
9.6.2 Insulin Pump
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital & Clinic
9.10.2 Retail Pharmacy
9.10.3 Online Sales
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Insulin Pens
10.6.2 Insulin Pump
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital & Clinic
10.10.2 Retail Pharmacy
10.10.3 Online Sales
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Insulin Pens
11.6.2 Insulin Pump
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital & Clinic
11.10.2 Retail Pharmacy
11.10.3 Online Sales
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Insulin Pens
12.6.2 Insulin Pump
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital & Clinic
12.10.2 Retail Pharmacy
12.10.3 Online Sales
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Insulin Pens
13.6.2 Insulin Pump
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital & Clinic
13.10.2 Retail Pharmacy
13.10.3 Online Sales
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insulin Pen and Pump Market: Competitive Dashboard
14.2 Global Insulin Pen and Pump Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novo Nordisk
14.3.2 Eli Lilly
14.3.3 Sanofi
14.3.4 BD
14.3.5 Ypsomed Holding
14.3.6 Dongbao
14.3.7 Owen Mumford
14.3.8 Ganlee
14.3.9 Medtronic
14.3.10 Roche
14.3.11 Insulet Corp
14.3.12 Tandem Diabetes care
14.3.13 Valeritas
14.3.14 SOOIL
14.3.15 Microport
